本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

奧洛茲美醫療

58.79
-0.0300-0.05%
盤後59.000.2100+0.36%19:37 EDT
成交量:151.93萬
成交額:8,914.16萬
市值:72.63億
市盈率:17.14
高:59.33
開:58.18
低:57.51
收:58.82
資料載入中...
2025/03/21

重要事件披露

Form 8-K - Current report
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/19

重要事件披露

Form 8-K - Current report
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/17

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities